- Home
- IMMP vs DH Comparison
IMMP vs DH Comparison
Compare IMMP & DH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- DH
- Stock Information
- Founded
- IMMP 1987
- DH 2011
- Country
- IMMP Australia
- DH United States
- Employees
- IMMP N/A
- DH N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- DH Computer Software: Prepackaged Software
- Sector
- IMMP Health Care
- DH Technology
- Exchange
- IMMP Nasdaq
- DH Nasdaq
- Market Cap
- IMMP 211.1M
- DH 280.0M
- IPO Year
- IMMP N/A
- DH 2021
- Fundamental
- Price
- IMMP $1.86
- DH $2.81
- Analyst Decision
- IMMP Buy
- DH Hold
- Analyst Count
- IMMP 2
- DH 11
- Target Price
- IMMP $8.50
- DH $5.35
- AVG Volume (30 Days)
- IMMP 648.0K
- DH 627.3K
- Earning Date
- IMMP 05-16-2025
- DH 05-08-2025
- Dividend Yield
- IMMP N/A
- DH N/A
- EPS Growth
- IMMP N/A
- DH N/A
- EPS
- IMMP N/A
- DH N/A
- Revenue
- IMMP $3,019,249.00
- DH $252,202,000.00
- Revenue This Year
- IMMP $11.25
- DH N/A
- Revenue Next Year
- IMMP $10.22
- DH $2.81
- P/E Ratio
- IMMP N/A
- DH N/A
- Revenue Growth
- IMMP 24.11
- DH 0.31
- 52 Week Low
- IMMP $1.32
- DH $2.15
- 52 Week High
- IMMP $3.34
- DH $7.47
- Technical
- Relative Strength Index (RSI)
- IMMP 53.43
- DH 53.20
- Support Level
- IMMP $1.44
- DH $2.65
- Resistance Level
- IMMP $2.71
- DH $2.88
- Average True Range (ATR)
- IMMP 0.17
- DH 0.11
- MACD
- IMMP 0.05
- DH 0.04
- Stochastic Oscillator
- IMMP 29.75
- DH 82.72
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About DH Definitive Healthcare Corp.
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.